Combination of Chemotherapy and Adaptive MR-Guided Radiotherapy to Improve Outcomes in Patients With Esophageal Adenocarcinoma

NCT07359443 · clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
39
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

UMC Utrecht

Collaborators